MONTREAL - Jubilant DraxImage Inc., a wholly owned subsidiary of Jubilant Pharma Limited, is pleased to announce the receipt of the CE Mark certificate for its state-of-the-art RUBY Rubidium Elution ...
At day's high, Jubilant Life Sciences shares recorded gains of more than 13 per cent in two trading sessions. Jubilant Life Sciences on Tuesday said its wholly-owned subsidiary has received approval ...
AMSTERDAM, Netherlands--(BUSINESS WIRE)--Sept. 3, 2003--DRAXIMAGE Inc., the radiopharmaceutical subsidiary of DRAXIS Health, Inc. (Nasdaq:DRAX)(TSX:DAX) presented new data on infection imaging at the ...
DRAXIMAGE, the radiopharmaceutical division of DRAXIS Health, has filed its DRAXIMAGE Sestamibi with European regulatory authorities. DRAXIMAGE Sestamibi is a generic kit for the preparation of Tc-99m ...
Addition of Mr. Kevin Brooks strengthens further Jubilant DraxImage expertise MONTREAL, April 2, 2013 /PRNewswire/ - Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, is ...
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., (“DraxImage”) www.draximage.com, a wholly Owned Subsidiary of Jubilant Pharma Ltd, announced today that the U.S. Food and Drug Administration has ...
NOIDA, India The Food and Drug Administration has approved a generic version of the drug used in myocardial perfusion imaging to evaluate the flow of blood to the heart. Jubilant Organosys announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback